Обоснование выбора антимикробных препаратов при амбулаторных инфекциях мочевыводящих путей
Диссертация
В России рациональный выбор антибиотика, при амбулаторных ИМП, имеет место в 49,2% случаев. Наиболее частыми ошибками являются — назначение препаратов с неустановленной эффективностью, с низкой микробиологической активностью или выбор препаратов не безопасных для плода. Наиболее информативными источниками рандомизированных контролируемых исследований для создания систематических обзоров… Читать ещё >
Содержание
- СПИСОК ИСПОЛЬЗУЕМЫХ СОКРАЩЕНИЙ
- НАЗВАНИЯ МИКРООРГАНИЗМОВ
Список литературы
- Андреева И.В. Фармакоэпидемиология антибактериальных препаратов у населения / Автореф. дис. канд. мед. наук.- Смоленск, 2003.- 21 с.
- Власов В.В. Как читать медицинские статьи: Часть 6. Практические рекомендации // Международный журнал медицинской практики.- 1998.- № 3.- 4−9.
- Журавлев В.Н., Ахметова Л. И., Сехин С В . Правила сбора мочи для бактериологического исследования и интерпретация его результатов // Клиническая антимикробная химиотерапия.- 1999.- № 1.- 109−112.
- Козлов Н. Фосфомицин / Глава в книге: Антибактериальная терапия: Практическое руководство. — 373 -Под редакцией Л. С. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 110−111.
- Лопаткин Н.А. Хронический пиелонефрит / Материалы Пленума Правления Всероссийского общеста урологов, Москва, 1996.- 107−125.
- Лопаткин Н.А., Деревянко И. И. Неосложненные и осложненные инфекции мочеполовых путей. Принципы антибактериальной терапии // Русский медицинский журнал.- 1997.- Vol. 24.- № 3.- 1579−1588.
- Лопаткин Н.А., Мартов А. Г. Состояние и перспективы развития урологической помощи в российской федерации // X Российский съезд урологов (отчет), 1−3 октября 2002 г., Москва.
- Лоран О. Б. Эпидемиологические аспекты инфекций мочевыводящих путей // Международный симпозиум «Инфекции мочевыводящих путей в амбулаторной практике». Тез. докл. — М., 1999. — 5 — 9 .
- Лоран О.Б., Пушкарь Д. Ю., Ратнер П. И. Осложненные инфекции мочевыводящих путей // Рус мед журнал.- 1999.- Том 1.- № 3.- 91−95.
- Лоран О.В., Рафальский В. В. Инфекции мочевыводящих путей Глава в книге: Антибактериальная терапия: Практическое руководство. Под редакцией Л. С. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 106−109.
- Люлько А.В., Волкова Л. Н., Суходольская А. Е. Цистит, Киев, Здоровье, 1988, — 176. — 374 —
- Морозов А.В. Хроническая инфекция мочевых путей (патогенез, принципы диагностики и лечения) // Русс. мед. журнал.- 2001.- Том 9.- № 23.- 1074−1077.
- Падейская Е.Н. Группа нитрофуранов / Глава в книге: Антибактериальная терапия: Практическое руководство. Под редакцией Л. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 103−106.
- Падейская Е.Н. Группа хинолонов/фторхинолонов / Глава в книге: Антибактериальная терапия: Практическое руководство. Под редакцией Л. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 73−79.
- Падейская Е.Н., Яковлев В. П. Фторхинолоны / Москва, 1995.- 208.
- Пушкарь Д.Ю., Тевлин К. П., Дьяков В. В. Фторхинолоны в урологии // Рус. Мед. Журнал.- 2002.-ТОМ 10.- № 8−9.- 414−417.
- Рафальский В. В. Нитроксолин. / Глава в книге: Антибактериальная терапия: Практическое руководство. Под редакцией Л. С. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 107−109.
- Сидоренко С В. Микробиологическая характеристика инфекций мочевыводящих путей / Материалы симпозиума: «Инфекции мочевыводящих путей у амбулаторных больных» 16 февраля 1999 г., Москва. — 1999.- 9−15.
- Сидоренко С В. Резистентность микроорганизмов и антибактериальная терапия // Русский медицинский журнал. — 1998. — Т. 6. — 717−725. — 375 —
- Сидоренко СВ., Козлов Н. Группа пенициллинов Глава в книге: Антибактериальная терапия: Практическое руководство. Под редакцией Л. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 47−56.
- Сидоренко СВ., Козлов Н. Группа цефалоспоринов Глава в книге: Антибактериальная терапия: Практическое руководство. Под редакцией Л. С. Страчунского, Ю. Б. Белоусова, Н. Козлова.- Москва, 2000.- 56−63.
- Синякова Л.А., Белобородов В. Б. Эмпирическая антибактериальная терапия гнойного пиелонефрита // Инфекции и антимикробная терапия.- 2002.- Том 4.-№ 1.- 23−29.
- Тиктинский О. Л. Воспалительные неспецифические заболевания мочеполовых органов / Л., Медицина, 1984.- 302.
- Тиктинский О.Л., Калинина Н. Пиелонефриты / Санкт-Петербург, 1996.- 238.
- Флетчер Р., Флетчер С, Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины / М., Медиа Сфера, 1998.- 347 с.
- Фролова М.В. Общие аспекты диагностики и лечения пиелонефритов в поликлинической практике / Материалы Пленума Правления Всероссийского общества урологов, Москва, 1996.- 212−3.
- Alho J.M. On prevalence, incidence, and duration in general stable populations // Biometrics. — 1992. — Vol. 48. — P. 587−592.
- Altman E.M., Lau J., Kupelnick В., Mosteller F., Chalmers Т. е. A comparison of results of metaanalyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction // JAMA.- 1992- Vol. 268-P.240−8. — 377 —
- American Medical Association, Office of Quality Assurance. Attributes to Guide the Developement and Evaluation of Practice Parameters / Chicago, 111: American Medical Association, 1990.- 329 p.
- Anderson J.D., Adams M.A., Barrington J.C., Spence W.N., Sheperd C.A. Comparison of the epidemiology of bacterial resistance to mecillinam and ampicillin // Antimicrob Agents Chemother.-1976.- Vol. 10.- P.872−877.
- Anderson R. Management of lower urinary tract infections and cystitis // Urologic Clin North Am.-1999.- Vol. 26.- P. 729−735.
- Andriole V.T. Use of quinolones in treatment of prostatitis and lower urinary tract infections // Eur J Clin Microb Infect Dis.- 1991.- Vol. 10.- P. 342−349.
- Antman E.M., Lau J., Kupelnick В., Mosteller F., and Chalmers I. A comparison of results of metaanalysis of randomised control trials and recommendations of clinical experts. Treatment for myocardial infarction // JAMA.- 1992.- Vol. 268.-P.240−8.
- Appel G.B., Neu H.C. The nephrotoxicity of antimicrobial agents // N Engl J Med.- 1977.- Vol. 292.- P. 663−69.
- Arason V.A., Kristinsson K.G., Sigurdsson J.A., et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? — 378 -Cross sectional prevalence study // BMJ. — 1996. -Vol. 313. — P. 387−391.
- Arav-Boger В., Leibovici L., Danon Y.L. Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment // Arch Intern Med.- 1994.-Vol. 154.- P.300−304.
- Arrieta A.C., Bradley J.S. Empiric use of cefepime in the treatment of serious urinary tract infections in children // Pediatr Infect Dis J.-2001.- Vol. 20.- 350−5.
- Asbach H.W. Single dose oral administration of cefixime ' 400 mg in the treatment of acute uncomplicated cystitis and gonorrhoea // Drugs.-1991.- Vol. 42 (suppl 4).- p. 10−14.
- Auquer F., Cordon F., Gorina E., Caballero J.C., Adalid C, Batlle J. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women // Clin Microbiol Infect 2002.-Vol. 8.- P.50−54.
- Bacheller CD., Bernstein J.M. Urinary tract infections // Med Clin North Am.-1997.- Vol. 81.-719−734.
- Bacheller CD., Bernstein J.M. Urinary tract infections // Med Clin North Am.- 1997.- Vol. 81.- P. 719−30.
- Backhouse C.I., Julie A., Matthews A. Single- Dose Enoxacin Compared with 3-Day Treatment for Urinary Tract Infection // Antimicrobial Agents and Chemotherapy.- 1989.- Vol. 33.- P. 877−880.
- Baerheim A., Digranes 0., Hunskaar S. Are resistance patterns in uropathogens published by microbiologic laboratories valid for general practice? // Acta Pathol Microbiol Immunol Scand.-1999.- Vol. 107.- P. 676−80.
- Ballow C.H., Schentag J.J. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group // Diagn Microbiol Infect Dis.- 1992.- Vol. 15(suppl 2).- S37−42.
- Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study // BMJ.- 2000.- Vol. 321.- P. 255−6. — 380 —
- Bass III P.F., Jarvis J.A.W., Mitchell C.K. Urinary tract infections // Prim Care.- 2003.- Vol. 30.- P. 41−61. — 381 —
- Baumgarten M. Designing prevalence and incidence stud-ies // Adv Wound Care. — 1998. — Vol. 11. — P. 287−293.
- Benson K., Hartz A.J. A comparison of observational studies and randomized, controlled trials // N Engl J Med.- 2000.- Vol. 342.- P. 1878−1886.
- Bergeron M.G. Treatment of pyelonephritis in adults // Med Clin North Am.-1995.- Vol. 619.- P. 209−214.
- Berman J.R., Zaran F.K., Rybak M.J. Pharmacy-based antimicrobial-monitoring service // Am J Hosp Pharm.- 1992.- Vol.49.- P.1701−1706.
- Berman J.R., Zaran F.K., Rybak M.J. Pharmacy-based antimicrobial-monitoring service // Am J Hosp Pharm.- 1992, — Vol. 49.- P. 1701−6.
- Berni G., Buiatti E., Conti A.A., Gensini G.F., Malucelli R., Panti A., Santoni S., Tomassini C.R. Appropriateness in the health system: past, present and future // Minerva Med.- 2003.- Vol. 94(3).- P. 129−34. — 382 —
- Bilo H.J.G., Lock M.T.W.T. Urinary tract infections // Mod Med.- 1995.- Vol. 19.- P. 298−304.
- Bloomfield P, Hodson EM, Craig JC. Antibiotics for acute pyelonephritis in children (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Bombardier C. Research challenges- overview of epidemi-ological study design // J Rheumatol. — 1998. — Vol. 15 (Suppl. 17). — P. 5−8.
- Booth C.C. The origin and growth of medical journals // Ann Intern Med.- 1990.- Vo. 113.- P. 398−402.
- Borderon E., Tescher M., Du Rouchet E., Lemaire В., Desroche A., Megier P. Urinary tract infection in gynecology-obstetrics: resistance to beta-lactam antibiotics and previous antibiotic therapy // Pathol Biol.- 1990.- Vol. 38.- P. 538−542.
- Bottiger L.E., Westerholm B. Adverse drug reactions during treatment of urinary tract infections // Eur J Clin Pharmacol.- 1977.- Vol. 11.-P. 439−442.
- Brenner & Rector’s / The Kidney, 5th ed. W. B. Saunders Company, 1996.- P.1633−1638.
- Brighton В., Bhandari M., Tornetta P. 3rd, Felson D.T. Hierarchy of evidence: from case reports to randomized controlled trials // Clin Orthop.-2003.- Vol. 413.-P. 19−24.
- Brumfitt W., Hamilton-Miller J.M. Limitations of and indications for the use of co-trimoxazole // J Chemother.- 1994.- Vol. 6.- P. 3−11.
- Brumfitt W., Hamilton-Miller J.M.T. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience // J Antimicrob Chemother.- 1998.- Vol. 42.- P. 363−71.
- Cahen P., Honderlick P. Nitrofurans: a modern treatment for uncomplicated urinary infections? // Pathol Biol (Paris).- 2000.- Vol. 48. — P. 470−1.
- Canadian Medical Association. Quality of Care Programme: The Guidelines for Canadian Clinical Practice Guidelines / Ottawa, Ontario: Canadian Medical Association, 1993.- 209 p.
- Cars 0., Molstad S., Melander A. Variation in antibiotic use in the European Union // Lancet. -2001. — Vol. 357. — P. 1851−1853. — 384 —
- Casas Rodriguez J, Pallares Robles J, Guarga Rojas A, Grifell Martin E, Marquet Palomer R. Amoxicillin/clavulanic acid and trimethoprim in the treatment of urinary infection in primary care // Aten Primaria.- 1990.- Vol. 7.- P. 127−30.
- Chalmers I., Egger M., Smith G.D., Altman D.G. Systematic reviews in health care: meta-analysis in context.- London: BMJ Publishing Group, 2001.- 487 p.
- Chalmers I., Trohler U. Helping physicians to keep abreast of the medical literature: Medical and Philosophical Commentaries, 1773−1795 // Ann Intern Med.- 2000.- Vol. 133.- P. 238−43.
- Chambers S.T. Cystitis and urethral syndromes. In: Armstrong D., Cohen J., editors / Infectious Diseases. W.B. Saunders Co.- 1999.- Vol. 1.- P. 57.1−57.8.
- Cheng Т.О. On the use of «incidence» and «prevalence» // J Clin Epidemiol. — 1998. — Vol. 51. — P. 365.
- Christensen B. Use of antibiotics to treat bacteriuria of pregnancy in the Nordic countries. Which antibiotics are appropriate to treat bacteriuria of pregnancy? // Int J Antimicrob Agents.- 2001.- Vol. 17.- P. 283−5.
- Christiaens T.C., Digranes A., Baerheim A. The relation between sale of antimicrobial drugs and antibiotic resistance in uropathogens in general practice // Scand J Prim Health Care. — 2002. — Mar- 20 (1). — P. 45−49. — 385 —
- Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.1.5 updated April 2002. In: The Cochrane 1. ibrary, Issue 2, 2002. Oxford: Update Software. Updated quarterly.
- Comite de 1'antibiogramme de la societe francaise de microbiologie (CA-SFM): report 2003. Zone sizes and MIC breakpoints for non-fastidious organisms (http://www.sfm.asso.fr/).
- Committee to Advice the Public Health Service on Clinical Practice Guidelines, Institute of Medicine. Field M.J., Lohr K.N., eds. Clinical Practice Guidelines: Directions of a new Programm.-Washington, DC: National Academy Press, 1990.- 378 p.
- Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs// N Engl J Med.- 2000.-Vol. 342.- P. 1887−1892.
- Cook D.J., Murlow CD., Haynes R.B. Systematic reviews: Synthesis of best evidence for clinical decisions / Ann Intern Med.- 1997.- Vol. 126.- 376−80.
- Cooper B. Pyelonephritis in non-pregnant women //Clin Evid.- 2002.- N.7.- P.1758−63.
- Cooper J, Raeburn AL, Brumfitt W, Hamilton- Miller JM. General practitioner study: fosfomycin trometamol versus amoxycillin clavulanate in acute urinary tract infections. Chemotherapy.- 1990.- Vol. 36 (Suppl 1).- P. 24−6. — 386 —
- Council of Europe. Developing a methodology for drawing up guidelines on best medical practices. (Recommendation and explanatory memorandum). / Z Arztl Fortbild Qualitatssich.- 2002.- Vol. 96.- Suppl 3.- P. 5−59.
- Сох C.E., Serfer H.S., Mena H.R., e.a. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection // Clin Ther.- 1992.- Vol. 14.- P. 446−457.
- Davey P.G., Malek M., Dodd Т., MacDonald T. Pharmacoeconomics and Drug prescribing. In: Avery’s Drug Treatment. 4th ed. Ed by Speight T.M., Holford H.G., et al. — 1997. — 393 p.
- Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections // Int J Antimicrob Agents.- 2001.- Vol. 18.- P. 211−215.
- Delzell J.E. Jr., Lefevre M.L. Urinary tract infections during pregnancy // Am Fam Physician.-2000.- Vol. 61.- P. 713−21.
- DerSimonian R., Laird N. Meta-analysis in clinical trials // Controlled Clinical Trials.-1986.- Vol. 7.- P. 177−188.
- Dickersin K., Scherer R., Lefebvre C. Identifying relevant studies for systematic reviews // BMJ.- 1994.- Vol. 309.- P. 1286−91.
- Dobrow M.J., Goel V., Upshur R.E. Evidence-based health policy: context and utilization // Soc Sci Med.- 2004.-Vol. 58(1): P. 207−17
- Dolan J.G., Bordley D.R., Polito R. Initial management of serious urinary tract infection: epidemiological guidelines // J Gen Intern Med.-1989.- Vol. 4.- P.190−4.
- Drlica K., Hoper D.C. Mechanisms of Quinolones Action / In: D.C. Hooper, E. Rubinstein ed. Quinolone Antimicrobial Agents, 3d edition.- Washington, D. C, ASM Press, 2003.- P. 19−41. — 388 —
- Duff P. Antibiotic selection for infections in obstetric patients // Semin Perinatol, — 1993.- Vol. 17.- P. 367−378.
- Eddy D.M. A Mannual for Assessing Health Practicies and Designing Practice Policies. The Explicit Approach / Philadelphia, Pa: American College of Physicians, 1992.- 420 p.
- Egger M., Smith G.D. Meta-Analysis. Potentials and promise // BMJ.- 1997.- Vol. 315.- 1371−4.
- Egger M., Smith G.D., Altman D.G. Systemaric Reviews in Health Care: Meta-analysis in context / 1. ondon, BMJ Publishing Group, 2001.- 486 p.
- Einarson T.R., Bergman U., Wiholm B.E. Principles and practice of pharmacoepidemiology // Avery’s Drug Treat-ment / Ed. Speight T.M., Holford N.H.G. — New Zealand: Adis International Limited- 1997. — P. 371−392.
- Ellis J., Mulligan I., Sacket D.L. Inpatient general medicine is evidence based // Lancet.-1995.- Vol. 346.- P. 407−10.
- Engel J.D., Schaeffer A.J. Evaluation of and antimicrobial therapy for recurrent urinary tract — 389 -infections in women // Urol. Clin. North Am.-1998.-Vol 25.- P. 685−701.
- Erikson N.H.R., Poulsen P.N., Frii H.M.U., Vejlsgaard. Urinvejsinfektioneraetiologi, diagnose og behandling med relevante antibiotika // Nord Med.-1989.- Vol. 104.- P. 35−38.
- Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group // JAMA.- 1993.- Vol. 269.- P. 1253−62.
- Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group // JAMA.- 1992.- Vol. 268.- P. 2420−5.
- Fahey Т., Griffiths S., Peters T.J. Evidence based purchasing: understanding results of clinical trials and systematic reviews // BMJ.- 1995.- Vol. 311.- P. 1056−9.
- Faro S. New considerations in treatment of urinary tract infections in adults // Urology. 1992. — Vol. 39.- P. 32−34
- Fihn S.D. Behavioral aspects of urinary tract infection // Urology.- 1988.- Vol. 33.- P. 16−8.
- Fihn S.D. Clinical practice. Acute uncomplicated urinary tract infection in women // N Engl J Med.-2003.- Vol. 349.- P. 259−66.
- Fihn S.D., et al. Association between diaphragm use and urinary tract infection // JAMA. — 1985. -Vol. 254.- P. 240−243. — 390 —
- Foxman В. Recurring urinary tract infection: Incidence and risk factors // Am J Public Health.-1990.- Vol. 80- P. 331−337.
- Foxman В., Klemstine K.L., Brown P.D. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality // Ann Epidemiol.- 2003.- Vol. 13.- P. 144−50.
- Foxman В., Marsh J., Gillespie B. Condom use and first time urinary tract infection // Epidemiology.-1997.- Vol. 8.- P. 637−41.
- Fraschini F., Scaglione F., Falchi M., Dugnani S., Mezzetti M., Cicchetti F., Alfano G., Pintucci G.P. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. J Chemother. 1990- 2:171−7.
- Freedman L.R. Natural history of urinary infection in adults // Kidney Int.- 1975.- Vol. 8.-P. S96-S100.
- Freeman J., Hutchison G.B. Prevalence, incidence and duration // Am J Epidemiol. — 1980. — Vol. 112. -P. 707−723.
- Friedman G.D. Medical usage and abusage: «prevalence» and «incidence» // Ann Intern Med. -1976. — Vol. 84. — P. 502−504.
- Funfstuck R., Smith J.W., Tschape H., Stein G. Pathogenetic aspects of uncomplicated urinary tract infection: recent advances // Clin Nephrol.- 1997.-Vol. 47.- P. 13−18. — 391 —
- Garcia-Rodriguez J.A., Munoz Bellido J.L. Oral cephalosporins in uncomplicated urinary tract infections // Clin Microbiol Infect.- 2000.- Vol. 6 Suppl 3.- P. 73−5.
- Geddes A.M. «Antibiotic therapy — a resume» // 1.ancet.- 1988.- Vol. 8580.- P. 286−9.
- Giamarellou H., Efstratiou A., Tsagarakis J., Petrikkos G., Daikos G.K. Experience with ciprofloxacin in vitro and in vivo // Arzneimittelforschung.- 1984.- Vol. 34.- P. 1775−1778.
- Gilstrap L.C.3d, Cunningham F.G., Whalley P.J. Acute pyelonephritis in pregnancy: an anterospective study // Obstet Gynecol.- 1981.- Vol. 57.- P. 409−13.
- Goettsch W., van Pelt W., Nagelkerke N., et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands // J Antimicrob Chemother. — 2000. — Vol. 46. — P. 223−228.
- Goldstein E.J., Kahn R.M., Alpert M.L., Ginsberg B.P., Greenway F.L., Citron D.M. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial // Am J Med.- 1987.-Vol. 82.- P. 284−287.
- Goto Т., Kitagawa Т., Kawahara M., Hayami H., Ohi Y. Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis // Hinyokika Kiyo.- 1999.- Vol. 45.- P. 85−89. — 392 —
- Greenland S., Robins J. Estimation of a common effect parameter from sparse follow-up data // Biometrics.- 1985.- Vol. 41.- P. 55−68.
- Greenland S., Salvan A. Bias in the one-step method for pooling study results // Statistics in Medicine.- 1990.- Vol. 9.- 247−252.
- Gregson P.R., Meal A.G., Avis M. Meta-analysis: the glass eye of evidence-based practice? // Nurs Inq.- 2002.- Vol. 9.- P. 24−30.
- Guay D.R. An update on the role of nitrofurans in the management of urinary tract infections // Drugs.- 2001.- Vol. 61.- P. 353−64.
- Guibert J., Herman H., Capron M.H. Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin // Contracept Fertil Sex.- 1997.- Vol. 25.- P. 79−84.
- Gupta K., Hillier S.L., Hooton T.M., et al. Effects of contraceptive method on vaginal microbial flora: a prospective evaluation // J Infect Dis.-2000.- Vol. 181.- Vol. 595−601.
- Gupta K., Naber K., Stamm W. Treatment of Urinary Tract Infectons / In: D.C. Hooper, E. Rubinstein ed. Quinolone Antimicrobial Agents, 3d edition.- Washington, D. C, ASM Press, 2003.- P. 159−171.
- Gupta K., Scholes D., Stamm W.E. Increasing Prevalence of Antimicrobial Resistance Among Uropathogens Causing Acute Uncoplicated Cystitis in Women // JAMA.- 1999.- Vol. 281.- P. 736−738. — 393 —
- Guzman-Bianco M., Casellas J. M., Sader H.S. Bacterial resistance to antimicrobial agents in latin America // Infect Dis Clin North Am.- 2000.- Vol. 14.- P.67−80.
- Hartzema A.G., Porta M.S., Tilson H.H. Introduction to pharmacoepidemiology // Drug Intell Clin Pharm. — 1987. — Vol. 21. — P. 739−740.
- Hayward R.S., Wilson M.C., Tunis S.R., Bass E.B., Rubin H.R., Haynes R.B. More informative abstracts of articles describing clinical practice guidelines // Ann Intern Med.- 1993.- Vol. 118.- 731−7.
- Hedges L.V., Olkin I. Statistical Methods for Meta-analysis / San Diego: Academic Press, 1985: Chapter 5.
- Henkel T.J., McKay D., Young C. Safety of Gemifloacin in Adult Patients With Respiratory and — 394 -Urinary Tract Infections / In: 3rd European Congress of Chemotherapy, 2000, Madrid, Spain.- 2000.- Poster M130.
- Hennessy S. Postmarketing drug surveillance: an epide-miologic approach // Clinical Therapeutics -1998. — Suppl. 20. — P. 32−39.
- Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women // New Engl J M. — 1971. — Vol. 284. — P. 878−881.
- Hernandez-Diaz S., Werler M.M., Walker A.M. et al. // NEJM.- 2000.- Vol. 343.- P. 1606−14
- Hessen M.T., Kaye D. Principles of selection and use of antibacterial agents. In vitro activity and pharmacology // Infect Dis Clin North Am.- 2000.-Vol. 14(2).- P. 265−79.
- Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis // Statistics in Medicine.- 2002.- Vol. 21.- P. 1539−1558
- Hirose Т., Okezaki E., Kato H., Ito Y., Inoue M., Mitsuhashi S. In vitro and in vivo activity of NY-198, a new difluorinated quinolone // Antimicrob Agents Chemother.- 1987.- Vol. 31.- P. 854−859.
- Hoberman A., Wald E.R. Intravenous Versus Oral Antibiotics for Urinary Tract Infections // Pediatrics.- 2000.- Vol. 106.- P. 234−235.
- Hooper D.C. Mechanisms of Quinolone Resistance / In: D.C. Hooper, E. Rubinstein ed. Quinolone — 396 -Antimicrobial Agents, 3d edition.- Washington, D.C., ASM Press, 2003.- P. 41−69.
- Hooper D.C. New uses for new and old quinolones and the challenge of resistance // Clin Infect Dis.-2000.- Vol. 30.- P. 243−54.
- Hooton T.M. Urinary tract infections / In: L.M. Baddour, S.L.Gorbach ed. Therapy of Infectious Diseases.- Saunders, 2003.- P. 449−467.
- Hooton T.M., Roberts P.L., Stamm W.E. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora // Clin Infect Dis.- 1994.- Vol. 19.- P. 274−278.
- Hooton T.M., Scholes D., Hughes J. et al. A prospective study of risk factors for symptomatic urinary tract infection in young women.- NEJM.-1996.- Vol. 335.- P. 468−474.
- Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection // Infect. Dis. Clin. North. Am.- 1997.- Vol. 11.- P. 551−81.
- Horcajada J.P. et al. Molecular epidemiology and evolution of resistance to quinolones in Eschrichia coli after prolonged administration of ciporfloxacin in patient with prostatitis // JAC. — 2002. — Vol. 49. — P. 55 — 59.
- Hovelius В., Mardh P.A. Staphylococcus saprophyticus as a common cause of urinary tract infections // Rev Infect Dis. — 1984. — Vol. — 6.- P. 328−337. — 397 —
- Huang E.S., Stafford R.S. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians // Arch Intern Med.-2002.- Vol. 162(1).- P.41−7.
- Ikaheimo R., Siitonen A., Heiskanen T. et al. Recurrence of urinary tract infection in a primary care setting: analysis of a one-year follow-up of 179 women // Clin Infect Dis.- 1996.- Vol. 22.- P. 91−99.
- Iravani A. Advances in the understanding and treatment of urinary tract infections in young women // Urology.- 1991.- Vol. 37.- P. 503−511.
- Iravani A. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults // American Journal of Medicine.- 1992.- Vol. 92.- P. 75S-81S. — 398 —
- Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections// Am J Med.- 1993.- Vol. 94.- P. 89S-96S.
- Jadad A.R., McQuay H.J. A high-yield strategy to identify randomized controlled trials for systematic reviews // Online J Curr Clin Trials.- 1993.- Vol. 27.- Doc No 33.
- Jardin A., Cesana M. Randomized, Double-Blind Comparison of Single-Dose Regimens of Rufloxacin and Pefloxacin for Acute Uncomplicated Cystitis in Women // Antimicrob Agent Chemother.- 1995.- Vol. 39.- P. 215−220.
- Jenkins R.D., Fenn J.P., Matsen J.M. Review of urine microscopy for bacteriuria // JAMA. — 1986. -Vol. 255. — P. 3397−3399.
- Jepson RG, Mihaljevic L, Craig JC. Cranberries for preventing urinary tract infections (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Jepson RG, Mihaljevic L, Craig JC. Cranberries for treating urinary tract infections (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Jick H., Rodriguez L.A.G., Perez-Gutthann S. Principles of epidemiological research on adverse and — 400 -beneficial drug effects // Lancet. — 1998. — Vol. 352. — P. 1767−1770.
- Johnson J.A., Bootman J.L. Drug-related morbidity and mortality. A cost-of-illness model // Arch Intern Med. — 1995. — Vol. 155. — P. 1949−1956.
- Johnson J.R. Virulence factors in Escherichia coli urinary tract infection // Clin Microbiol Rev.-1991.- Vol. 4.- P. 80−128.
- Johnson J.R., Stamm W.E. Urinary tract infections in women: diagnosis and treatment // Ann Intern Med.- 1989.- Ill: 906−917.
- Kadiri S., Ajayi S.O., Toki R.A. Quinolones for short-term treatment of uncomplicated urinary tract infection // East Afr Med J.- 1999.- Vol. 76.- P. 587−589.
- Kahlmeter G. An International Survey of the Antimicrobial Susceptibility of pathogens from Uncomplicated Urinary Tract Infections: the ECO-SENS Project // J Antimicrob. Chemother.- 2003.- Vol 51.-P. 69−76.
- Kantor A.F., Hartge P., Hoover R.N., Narayana A.S., Sullivan J.W., Fraumeni J.F. Urinary tract infection and risk of bladder cancer // Am J Epidemiol.- 1984.- Vol. 119.- P.510−5.
- Karam D., Amgar A., Bourlioux P. Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline // Pathol Biol (Paris).- 1988.- Vol. 36.-P.452−455. — 401 —
- Karkkainen U-M., Ikaheimo R., Katila M-L., Siitonen A. Recurrence of urinary tract infections in adult patients with pyelonephritis caused by E. coli: A 1-year follow-up // Scand J Infect Dis.- 2000.-Vol. 32.- P. 495−9.
- Karlowsky J.A., Thornsberry C, Jones M.E., Sahm D.F. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin // Clin Infect Dis.- 2003.- Vol. 36.- P. 183−7.
- Kass E.H. Asymptomatic infections of the urinary tract // Trans Assoc Am Physicians.- 1956.- Vol. 69.-P. 56−63.
- Kass E.H. Bacteriuria and the diagnosis of infections of the urinary tract // Arch Intern Med 1957.- Vol. 100.- P. 709−14.
- Kass E.H. Pregnancy, pyelonephritis and prematurity // Clin Obstet Gynecol, — 1970.- Vol. 13.-P. 239−54.
- Kass E.H. Pyelonephritis and bacteriuria: a major problem in preventive medicine // Ann Intern Med.- 1962.- Vol. 56.- P. 46−53. — 402 —
- Keren R., Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics. 2002. 109(5).
- Khan A.J. Efficacy of single-dose therapy of urinary tract infection in infants and children: a review // Journal of the National Medical Association.- 1994.- Vol. 86.- P. 690−6.
- Kish M.A. Guide to development of practice guidelines // Clin Infect Dis.- 2001.- Vol.- 32.-851−4.
- Kish M.A. Infectious Diseases Society of America. Guide to development of practice guidelines // Clin. Infect. Dis.- 2001.- Vol. 32.- P.851−4.
- Kouri T, Fogazzi G, Gant V, Hallander H, Hofmann W, Guder WG (Editors: ECLM — European Urinalysis Group). European urinalysis guidelines. The Scandinavian Journal of Clinical & Laboratory Investigation.- 2000.- Vol. 60.- Suppl. 231.- p. 1−96.
- Krcmery S., Hromec J., Demesova D. Treatment of lower urinary tract infection in pregnancy // Int J Antimicrob Agents.- 2001.- Vol. 17.- 279−82.
- Kumazawa J., Matsumoto T. Complicated Urinary Tract Infections. Bergan T (ed): Urinary Tract Infections / Infectiology. Basel, Karger, 1997.- P. 19−26. — 403 —
- Kunin C M. Evaluation of antibiotic usage: A comprehensive look at alternative approaches // Rev Infect Dis.- 1981.- Vol. 3.- P. 745−752.
- Kunin C M. Urinary tract infections in females (State-of-the-art) // Clin Infect Dis.- 1994.- Vol. 18.- P. 1−10.
- Kunin СМ., White L.V., Tong H.H. A reassessment of the importance of «low-count» bacteriuria in young women with acute urinary symptoms // Ann Intern Med.-1993.- Vol. 119.- P. 454−460.
- Kunin CM. Asymptomatic bacteriuria. Annu Rev Med 1966−17:383−406.
- Kunz R., Oxman A.D. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials// BMJ.-1998.-Vol. 7167.- 1185−1190.
- Labeling requirements for systemic antibacterial drug products intended for human use. Food and Drug Administration. 21 CFR Part 201. Docket №. 00N-1463. RIN 0910-AB78. Available from: http://www.fda.gov/OHRMS/DOCKETS/98fr/9 1900c.htm.
- Last J.M. A dictionary of epidemiology. New York: Oxford University Press- 1988:81.
- Lau J., Antman E.M., Jimenez-Silva J., Kupelnick В., Mosteller F., and Chalmers I. Cumulative metaanalysis of therapeutic trials for myocardial infarction // N Engl J Med.- 1992.- Vol. 327.- P. 248−54. — 404 —
- Lawson D.H. Pharmacoepidemiology: a new discipline // BMJ (Clin Res Ed). — 1984. — Vol. 289. — P. 940−941.
- Lazarou J., Pomeranz В., Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies // JAMA. — 1998. — Vol. 279. — P. 1200−1205.
- Le Т., Miller L. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis // Clin Infect Dis.- 2001.- Vol. 33.-P. 615−21.
- Lee J.A.H., Draper P.A., Weatherall M. Prescribing in three English towns // Milbank Mem Fund Q. — 1965. — Vol. 43. — P. 285−290.
- Leelarasamee A., Leelarasamee I. Comparative efficacies of oral pefloxacin in uncomplicated cystitis. Single dose or 3-day therapy. Drugs 1995−49(Suppl 2):365−7.
- Leibovici L. Wysenbeek A.J. Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomized trials // Quarterly Journal of Medicine.- 1991.- Vol. 78.- Vol. 43−57.
- Leibovici L., Shraga I., Andreassen S. // How do you choose antibiotic treatment? BMJ.- 1999.- Vol. 318(7198).- P.1614−6.
- Lenti G, Pellegrini A, Pagano PG. Clinical use of the new penicillins in general medicine with particular regard to urinary infections // Minerva Med.- 1965.- Vol. 56.- P. 3085−3090.
- Levy S.B. Confronting multidrug resistance: A role for each of us.- JAMA.- 1993.- Vol. 269.-P.1840−1850.
- Levy S.B. Multidrug resistance — a sign of the times // N Engl J Med.- 1998.- Vol. 338.- P.1376−1378.
- Lipman Т., Price D. Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice // BMJ.- 2000.- Vol. 320.- P. 1114−8.
- Loran O.B., Pushkar' D.Iu., Tevlin K.P. Experience with the use of ciprofloxacin in patients with acute uncomplicated cystitis // Antibiot Khimioter.- 1997.- Vol. 42.- 42−44.
- Lorian V., Burns L. Predictive value of susceptibility tests for the outcome of antibacterial therapy // J Antimicrob Chemother.- 1990.- Vol. 25.-P. 175−182.
- Lucas M., Cunningham F. Urinary infection in pregnancy // Clin Obstet Gynecol. — 1993. — Vol. 36. — P. 855−68. — 406 —
- Ludwig G. Experience with clinical use of ofloxacin in the treatment of upper and lower urinary tract infections. Demonstration of the result of four clinical trials // Antibiot Khimioter.- 1996.- Vol. 41.- P. 84−85.
- Lugg J.A. US and European Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis in Women: How to Benefit From Both // Infect Urol.- 2003.- Vol. 16.- P. 59−64.
- Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Malinverni R., Glauser M.P. Comparative studies of fluoroquinolones in the treatment of urinary tract infections // Rev Infect Dis.- 1988.- Vol. 10.- S153−63.
- Marple C D. The frequency and character of urinary tract infections in an unselected group of women // Ann Intern Med.- 1941.- Vol. 14, — P. 2220−30.
- Masterton R., Bochsler J. High dosage co- amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women // J Antimicrob Chemother.- 1995.- Vol. 35.- P. 129−37.
- Masterton R.G., Bochsler J.A. High-dosage co- amoxiclav in a single dose versus 7 days of со-- 407 -trimoxazole as treatment of uncomplicated lower urinary tract infection in women // J Antimicrob Chemother.- 1995.- Vol. 35.- P. 129−37.
- Matthew E., Gorbach S.L. Practice guidelines: urinary tract infections.- IDCP.-1995.- Vol.4.- P. 241−254.
- Matzke G.R., Frye R.F. Drug administration in patients with renal insufficiency: Minimizing renal and extrarenal toxicity // Drug Safety.- 1997.- Vol. 16.- P. 205−212.
- McBride W.G. Thalidomide and congenital abnormalities // Lancet. — 1961. — Vol. 2. — P. 1358.
- McDermott S., Callaghan W., Szwejbka L., Mann H., Daguise V. Urinary tract infections during pregnancy and mental retardation and developmental delay // Obstet Gynecol.- 2000.- Vol. 96.- P. 113−9.
- McMahon A.D., McDonald T.M. Design issues for drug epidemiology // Br J Clin Pharmacol. — 2000. -Vol. 50. — P. 419−425.
- Meade T.W. Prescribing of chloramphenicol in general practice // BMJ. — 1967. — Vol. 1. — P. 671−674. — 408 —
- Meares E.M. Current patterns in nosocomial urinary tract infections // Urology.- 1991.- Vol. 37.- P. 9−12.
- Meares Jr. E.M. Asymptomatic bacteriuria // Postgrad Med.- 1977.- Vol. 62.- P. 106−11
- Meijman F.J. The Dutch College of General Practitioners' guideline on urinary tract infections: response from the viewpoint of family practice // Ned Tijdschr Geneeskd.- 2001.- Vol. 145.- 716−7.
- Melekos M. D, Naber K.G. Complicated urinary tract infections. Int J Antimicrob Agents, 2000- 15(4): 247−56.
- Miall W.E., Kass E.H., Ling J., Stuart K.L. Factors influencing arterial pressure in the general population in Jamaica // BMJ.- 1962.- P. 497−506.
- Michael M, Hodson EM, Craig JC, Martin S, Moyer VA. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Mikhail M.S., Anyaegbunam A. Lower urinary tract dysfunction in pregnancy: a review // Obstet Gynecol Surv.- 1995.- Vol. 50.- 675−83.
- Mikhail M.S., Anyaegbunam A. Lower urinary tract dysfunction in pregnancy: a review // Obstet Gynecol Surv.- 1995.- Vol. 50.- P.675−83.
- Mincey В., Parkulo M. Antibiotic prescribing practices in a teaching clinic: comparison of — 409 -resident and staff physicians // South Med J. — 2001. — Vol. 94. — P. 365−369.
- Mockenhaupt M., Schopf E. / Progress in Allergy and Clinical Immunology, vol. 4, Cancun (Mexico): proceedings of the XVIth International Congress of Allergology and Clinical Immunology, Cancun, Mexico, 1997.- P. 352−360.
- Mohammad M., Mahdy Z.A., Omar J., Maan N., Jamil M.A. Laboratory aspects of asymptomatic bacteriuria in pregnancy // Southeast Asian J Trop Med Public Health.- 2002.- Vol. 33.- P. 575−80.
- Mouton R.P., Hermans J., Simoons-Smit A.M., et al. Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci // J Antimicrob Chemother. — 1990. -Vol. 26. — P. 573−583.
- Mulrow C D. The medical review article: state of the science // Ann Intern Med.- 1987.- Vol. 106.- P. 485−8.
- Murray B.E. Can antibiotic resistance be controlled? // N Engl J Med.- 1994.- Vol.330.-P.1229−1233. — 410 —
- Naber K.G. Use of quinolones in urinary tract infections and prostatitis // Rev Infect Dis. — 1989. — Vol. ll (suppl 5). — P. S1321−1334.
- Naber K.G., di Silverio F., Geddes A., Guibert J. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection // J Antimicrob Chemother.- 1996.-Vol. 37.- P. 135−144.
- Nelson R. Drug safety, pharmacoepidemiology, and regu-latory decision-making // Drug Intell Clin Pharm. — 1988. — Vol. 22. — P. 336−344.
- Neu H.C., Howrey S.P. Testing the physician’s knowledge of antibiotic use: Self-assessment and learning via videotape // N Engl J Med.- 1975.- Vol. 293.- P. 1291−1299.
- Nicolle L.E. A practical guide to the management of complicated urinary tract infection // Drugs.-1997.- Vol. 53.- P. 583−592.
- Nicolle L.E. Epidemiology of Urinary Tract Infection // Infect Med.- 2001.- Vol.18.- P. 153−162.
- Nicolle L.E. Epidemiology of Urinary Tract Infection // Infect Med.- 2001.- Vol. 18.- P. 153−162.
- Nicolle L.E. Urinary Tract Infection: Traditional Pharmacologic Therapies // Am J Med.-2002.- Vol. 113(1A).- P. 35S-44S.
- Nicolle L.E., Harding G.K., Preiksaitis J. The association of urinary tract infection with sexual intercourse // J Infect Dis. — 1982 — Vol. 146. — P. 579−582.
- Nicolle L.E., Ronald A.R. Recurrent urinary tract infection in adult women: Diagnosis and treatment // Infect Dis Clin North Am. — 1987. — Vol. 1. — P. 793−806.
- Nishibori M. What is the systematic review? // Rinsho Byori.- 2003.- Vol. 51.- P.678−81.
- Norrby R. Short-term treatment of uncomplicated urinary infections in women // Rev. Infect. Dis.-1990.- Vol. 12.- P. 458−467.
- Norrby S.R. Short term treatment of uncomplicated lower urinary tract infections in women. // Rev Infect Dis. — 1990. — Vol. 12. — P. 458−467.
- Norrby S.R. Urinary tract infections. In: Antibiotic and Chemotherapy, seventh edition. Ed. by — 413 -F.0'Grady, H.P.Lambert, R.G.Finch, D.Greenwood. Churchill Livingstone, NY, 1997.- P. 792−9.
- O’Connor P.J., Solberg L.I., Christianson J., et al: Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO // Jt Comm J Qual Improv.- 1996.- Vol. 22.- P.673−678.
- Oliphant СМ., Green G.M. Quinolones: a comprehensive review // Am Fam Physician.- 2002.- Vol 65.- P.455−64.
- Oliviero L., Perdiz M., Bourlioux P. Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters // Pathol Biol (Paris).- 1990.- Vol. 38.- P. 455−458. — 414 —
- Orenstein R., Wong E.S. Urinary tract infections in adults // Am Fam Physician.- 1999.- Vol. 59.- P. 1225−34
- Orenstein R., Wong E.S. Urinary tract infections in adults // Am Fam Physician.- 1999.- Vol. 59.- P. 1225−34.
- Oxman A.D., Guyatt G.H. Guidelines for reading literature reviews // CMAJ.- 1988.- Vol. 138.- P.697−703.
- Pappas P.G. Laboratory in the diagnosis and management of urinary tract infections // Med Clin North Am. — 1991. — Vol. 75. — P. 316−324.
- Pastore L. Predictors of urinary tract infection at the first prenatal visit // J Perinatol. — 1999. -Vol. 19. — P. 488−93.
- Patrick M. Influence of maternal renal infection on the foetus and infant // Arch Dis Child.- 1967.-Vol. 46.- P. 208−13.
- Patterson Т., Andriole V. Bacteriuria in pregnancy // Infect Dis Clin North Am. — 1987. — Vol. 1. — P. 807−22.
- Patterson T.F., Andriole V.T. Bacteriuria in pregnancy. Infect Dis Clin North Am 1987- 1: 807−22.
- Patterson T.F., Andriole V.T. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am.- 1997.- Vol. 11.- P. 593−608. — 415 —
- Patton J.P., Nash D.B., Abrutyn E. Urinary tract infection: Economic considerations // Med Clin North Am. — 1991.- Vol. 75.- P. 495−512.
- Paulus W.E. Pharmacotherapy in pregnancy // Ther Umsch. — 1999. — Vol. 56. — P. 602−607.
- Perri M.B., Hershberger E., Ionescu M., Lauter C, Zervos M.J. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin // Diagn Microbiol Infect Dis.- 2002.- Vol. 42.- P. 269−71.
- Pestotnik S.L., Classen D.C., Evans R.S., et al: Implementing antibiotic practice guidelines though computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med.- 1996.- Vol. 124.- P. 885−893.
- Pezzlo M. Detection of urinary tract infections by rapid methods // Clin Microbiol Rev.- 1988.- Vol. 2.- P. 268−280.
- Pezzlo M. Urine Culture Procedures. In: Isenberg H.D., editor. Clinical Microbiology Procedures.-1992.- 1.17.6 — 1.17.7.
- Pichichero M.E. (ed): Cost-containment strategies in antibiotic therapy // Hospital Practice.- 1996.- Vol. 31 (Suppl 1).
- Pinson A., Philbrick J., Lindbeck G., Schorling J.В. ED management of acute pyelonephritis in women: a cohort study // Am J Emerg Med. — 1994.- Vol. 12.-P. 271−8.
- Pippo Т., Pitkajarvi Т., Salo S.A. Three-day versus seven-day treatment with norfloxacin in acute cystitis // Cur Therap Res.- 1990.- Vol. 47.- P. 644−653.
- Porta M.S., Hartzema A.G. The contribution of epidemi-ology to the study drugs // Drug Intell Clin Pharm. — 1987. — Vol. 21. — P. 741−747.
- Radandt J.M., Marchbanks C.R., Dudley M.N. Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management // Clin Infect Dis, — 1992.- Vol. 14.-P.272−279.
- Rafalsky V, Andreeva I, Rjabkova E. Quinolones for uncomplicated acute cystitis in women protocol. In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software. Updated quarterly.
- Ray W.A. Pharmacoepidemiology: is ignorance bliss? // J Clin Res Drug Dev. — 1998. — Vol. 2. — P. 67−74.
- Raz R., Gennen Y., Wasser J., et al. Recurrent urinary tract infection in postmenopausal women // Clin Infect Dis.- 2000.- Vol. 30.- P. 152−156.
- Recommendations from an expert meeting. Treatment of urinary tract infections // 1.akartidningen.- 1990.- Vol. 87, — P.3098−3105.
- Richman P., Garra G., Eskin В., et al. Oral antibiotic use without consulting a physician: a survey of ED patients // Am J Emerg Med. — 2001. -Vol. 19. — P. 57−60.
- Roberts J.A. Management of pyelonephritis and upper urinary tract infections // Urologic Clinics of North America.- 1999.- Vol. 26.- P. 753−60.
- Roberts J.A.M. Management of pyelonephritis and upper urinary tract infections // Urol Clin North Am.- 1999.- Vol. 26.- P. 753−63.
- Robins J., Greenland S., Breslow N.E. A general estimator for the variance of the Mantel-Haenszel odds ratio // American Journal of Epidemiology.-1986.- Vol. 124.- Vol. 719−723.
- Robinson K.A., Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed // Int J Epidemiol.- 2002.- Vol.31.- P.150−3.
- Robinson M.J., Pash J., Grimwade J., Campbell J. Fetal warfarin syndrome // Med J Aust. — 1978. — Vol. 1. — P. 157.
- Ronald A.R., Harding G. K.M. Complicated urinary tract infections // Infect Dis Clin North Am.- 1997.-Vol. 11.- P. 583−592.
- Ronald A.R., Nicolle L.E., Harding G.K. Standards of therapy for urinary tract infections in adults // Infection.- 1992.- Vol. 20(suppl 3).- P. S164−170.
- Rosenblatt J.E. Laboratory tests used to guide antimicrobial therapy // Mayo Clin Proc- 1991.-Vol. 66.- P. 942−951.
- Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV, editors. The Handbook of Research Synthesis. New York: Russell Sage Foundation, 1994.
- Roujeau J.C., Kelly J.P., Naldi L. e.a. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis // N Engl J Med.- 1995.- Vol. 333.- P.- 1600−1607.
- Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs // N Engl J Med.- 1994.-Vol. 331.- P.1272−1285.
- Rubenstein J.N., Schaeffer A.J. Managing complicated urinary tract infections: the urologic view // Infect Dis Clin North Am.- 2003.- Vol. 17.-P.333−351.
- Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection // - 420 -Clin Infect Dis.- 1992.- Vol. 15(suppl 1).- P. S216−27.
- Russo Т., Stapelton A., Stamm W.E. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women // J Infect Dis.-1995.- Vol. 172.- P. 440−445.
- Sackett D.L., Rosenberg W.M., Gray J.A., Haynes R.B., Richardson W.S. Evidence based medicine: what it is and what it isn’t // BMJ. — 1996. — Vol. 312. -P. 71−72.
- Safrin S., Siegel D., Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy // Am J Med.- 1988.- Vol. 85.- P. 793−798.
- Saginur R., Nicolle E. Single-dose Compared With 3-Day Norfloxacin Treatment of Uncomplicated Urinary Tract Infections in Women // Arch Intern Med.- 1992.-Vol. 152.- P.1233−7.
- Saginur R., Nicolle L.E. Canadian Clinical Trials Study Group: Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infections in women // Arch Intern Med.- 1992.- Vol. 152.- P.1233.
- Saint S., Scholes D., Fihn S.D., Farrell R.G., Stamm W.E. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women // Am J Med.- 1999.- Vol. 106. — P. 636−41. — 421 —
- Sanford J.P. Urinary tract symptoms and infections // Ann Rev Med.- 1975.- Vol. 25.- P. 485.
- Schaeffer A.J. Infection of urinary tract / Campbell’s Urology, 7-th Edition, 1998.- P. 533−614.
- Schaeffer A.J. Infections of the urinary tract / In P.C. Walsh, A.B. Retik, E.D. Vaughan, A.J. Wein (eds): Campbell’s Urology, ed 7. Philadelphia, WB Saunders, 1998.- P. 870.
- Schaeffer A.J. The expanding role of fluoroquinolones // Am J Med.- 2002.- Vol. 113.- P. 45S-54S.
- Schaeffer A.J. Urinary tract infection in men— state of the art // Infection.- 1994.- Vol. 22(suppl 1).- P. S19−21.
- Schaeffer A.J. Urinary tract infections: antimicrobial resistance // Current Opinion in Urology.- 2000.- Vol. 10.- P. 23−24.
- Schaeffer A.J., Stuppy B.A. Efficacy and safety of self-start therapy in women with recurrent urinary tract infection // J Urol.- 1999.- Vol. 16.- P. 207−211.
- Schmaldienst S., Horl W.H. Bacterial infections after renal transplantation // Nephron, — 1997.- Vol. 75.- P. 140−153.
- Schutz W. Treatment of uncomplicated urinary tract infections. Effectiveness and tolerance of sultamicillin compared with amoxicillin/clavulanic acid // Fortschr Med.- 1990.- Vol. 108, — P. 365−368. — 422 —
- Sheehan R.E., Wells A.U., Milne D.G., Hansell D.M. Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities // J Comput Assist Tomogr.- 2000.-Vol. 24.- P. 259−61.
- Shevchuk Y. Antibiotic resistance: whose responsibility is it? // Can Pharm J. — 2002. — Vol. 135. — P. 27.
- Shrestha N.K., Tomford J.W. Fosfomycin: A Rewiew // Infectious Diseases in Clinical Practice.- 2001.-Vol. 10.- P. 255−260.
- Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Sobel J.D., Kaye D. Urinary tract infections / In Mandel’s Principals and practice of infectious diseases, 1995.- P. 1290.
- Sobel J.D., Kaye D. Urinary tract infections. In Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, ed 4, Vol 1. New York, Churchill Livingstone, 1995. — 423 —
- Sobol J.D. Bacterial etiologic agents in the pathogenesis of urinary tract infection // Med Clin North Am.- 1991.- Vol. 75.- P. 253−273.
- Speight T.M., Nicholas H.G. Holford Drug Treatment, 4th Edition. — Maiden, MA: Blackwell Science for Adis In-ternational, Auckland NZ, 1997. -1852 p.
- Spitzer W.O., Lewis M.A., Heinemann L.A.J., e.a. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study // BMJ. — 1996. — Vol. 312. — P. 83−88.
- Stamey T.A., Fair W.R., Timothy M.M., et al: Serum versus urinary antimicrobial concentration in case of urinary tract infection // N Engl J Med.-1974.- Vol. 291.- P. 1159−1163.
- Stamm W.E., Hooton T.M. Management of urinary tract infections in adults // N Engl J Med.- 1993.-Vol. 329.- P. 1328 -1334.
- Stamm W.E., Stapleton A.E. Approach to the Patient with Urinary Tract Infections. In: Gorbach S.L., Bartlett J.G., Blacklow N.R., editors / Infectious Diseases. W.B. Saunders Co., 1998.- P. 943−954.
- Stamm W.E.H., Thomas M. Current concepts: management of urinary tract infections in adults // N Engl J Med.- 1993.- Vol. 329.- P. 1328−34.
- Stein G.E. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection // Clin Ther.- 1999.- Vol. 21.- P. 1864−72.
- Stein G.E., Philip E. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women // J Fam Pract.-1992.- Vol. 34.- P. 180−184.
- Stelck M. Microbial warfare: the front lines of antibi-otic resistance // The surgical technologist. — 1999. — Vol.31. — P. 10.
- Striano V. On clinical results obtained with a new antibiotic in infections of the urinary tracts (ampicillin) // Minerva Urol.- 1965.- Vol.17.- P. 121−4.
- Strom B.L. What is pharmacoepidemiology? // Pharma-coepidemiology / Ed. Strom B.L. — New York: John Wiley & Sons, Inc.- 1994. — P. 3−15.
- Svanborg C, Godaly G. Bacterial virulence in urinary tract infection // Infect Dis Clin North Am.-1997.- Vol. 11.- P. 513−530.
- Switzer S. Bacteriuria in a healthy population and its relation to hypertension and pyelonephritis // N Engl J Med.- 1961.- Vol. 264.- P.7−10. — 425 —
- Teagarden J.R. Meta-analysis: whither narrative review? // Pharmacotherapy.- 1989.- Vol. 9.- P. 274−81.
- Tehan S., Lamb Y.J. Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice // J Antimicrob Chemother.- 1989.- Vol. 24.- P.235−9.
- Thauvin C, Eliopoulos G.M. Activity In Vitro of the Quinolones / In: D.C. Hooper, E. Rubinstein ed. Quinolone Antimicrobial Agents, 3d edition.-Washington, D. C, ASM Press, 2003.- P. 91−115.
- The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- The Inter-Nordic Urinary Tract Infection Study Group. Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections // Scand J Infect Dis.- 1988.- Vol. 20.- P. 619−624.
- The Rational Use of Drugs. Reports of the Conference of Experts, Nairobi, Nov. 25−29, 1985. -Geneva, World Health Organization, 1987.
- Thompson K.S., Sanders W.E., Sanders C.C. USA resistance patterns among UTI pathogens // J — 426 -Antimicrob Chemother.- 1994.- Vol. 33(suppl A) .- P. 9−15.
- Tichacek B. Epidemiologic methods and their application // Cesk Epidemiol Mikrobiol Imunol. -1989. — Vol. 38. — P. 129−136.
- Tilson H.H. Pharmacoepidemiology: the future // Drug Intell Clin Pharm. — 1988. — Vol. 22. — P. 416−421.
- Tomasz A. Multiple antibiotic resistant pathogenic bacteria // N Engl J Med.- 1994. Vol. 330.- P.1247−51.
- Tomera K.M., Burdmann E.A., Reyna O.G., Jiang Q., Wimmer W.M., Woods G.L., Gesser R.M.- Protocol
- Tran D., Muchant D. G., Aronoff S. С Short- course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients. Journal of Pediatrics. 2001. 139(1). 93−99.
- Tsukamoto Т., Matsukawa M., Sano M., Takahashi S., Hotta H., Itoh N., Hirose Т., Kumamoto Y. Biofilm in complicated urinary tract infection // Int. J. Antimicrob. Agents, 1999.- Vol. 11.- P. 233−236.
- Vazquez JC, Villar J. Treatments for symptomatic urinary tract infections during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software. — 428 —
- Vercaigne L.M., Zhanel G.G. Recommended treatment for urinary tract infection in pregnancy // Ann Pharmacother.- 1994.- Vol. 28.- P. 248−51.
- Vickrey B.G., Shekelle P., Morton S., Clark K., Pathak M., Kamberg C. Prevention and management of urinary tract infections in paralyzed persons. 1999. 1−34. Rockville, MD, USA: Agency for Health Care Policy and Research.
- Vosti K.L. Infections of the urinary tract in women: a prospective, longitudinal study of 235 women observed for 1−19 years // Medicine (Baltimore).-2002.- Vol. 81.- P. 369−87.
- Walker G.J.A., Hogerzeil H.V., Sallami A.O., et al. Evaluation of rational drug prescribing in Democratic Yemen // Soc Sci Med. — 1990. — Vol. 31. -P. 823−828.
- Wan Po A. L. Evidence-Based Pharmacotherapy // The Pharmaceutical Journal. — 1996. — Vol. 256. — P. 308−312.
- Ward T.T., Jones S.R. Genitourinary Tract Infections / In: E. Reese, F.B. Robert: Practical Approach to Infectious Diseases, 4th ed., 1996.-P.1632−1639. — 429 —
- Ward Т.Т., Jones S.R. Genitourinary Tract Infections. In: E. Reese, F.B. Robert: Practical Approach to Infectious Diseases, 4th ed., 1996.-P.1632−1639.
- Ward T.T., Jones S.R. Genitourinary tract infections: Catheter-associated UTI. In Reese RE, Betts RF (eds) / A Practical Approach to Infectious Diseases, ed 3. Boston, Little, Brown. -1991. — P. 381−382.
- Warren J.W. Catheter-associated urinary tract infections // Infect Dis Clin North Am.- 1987.- Vol. 1.- P. 823−854.
- Warren J.W., et al. A prospective microbiologic study of bacteriuria in patients with indwelling urethral catheters // J Infect Dis.- 1982.- Vol. 146.- P. 719−723.
- Wemeau L, Mazeman E, Stankowiak C. Clinical trials of ampicillin in urology // Gaz Med Fr.-1966.- Vol. 73.- P. 132−7.
- Whalley P. Bacteriuria of pregnancy / Am J Obstet Gynecol.- 1967.- Vol. 97.- P. 723−738.
- Whalley P. Bacteriuria of pregnancy // Am J Obstet Gynecol.- 1967.- Vol. 97.- P. 723−38. — 430 —
- White T.J. Counting the cost of drug-related adverse events // Pharmacoeconomics. — 1999. — Vol. 15. — P. 445−458.
- WHO collaborating centre for drug statistics methodology guidelines for АТС classification and DDD assignment. — Oslo: WHO collaborating centre for drug statistics methodology, 2001. — 262 p.
- Williams G, Lee A, Craig J. Antibiotics for the prevention of urinary tract infection in children: a systematic review of randomized controlled trials. Journal of Pediatrics. 2001. 138(6). 868−874.
- Williams GJ, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
- Willioox P.A., Maze S.S., Sandler M., Benatar S.R. // S Afr Med J.- 1982.- Vol. 61.- P. 714−717.
- Wilson-Davis K. Study design and the use of statistics in drug use research // Handbook of Drug Use Research Methodology / Ed. McGavock H. Newcastle: The United Kingdom Drug Utilization Research Group, 2000. — P. 36−55.
- Wittenberger R. Ofloxacin versus pipemidic acid and co-trimoxazole // Infection, — 1986.- Vol. 14.- P. S93−6.
- Woolf S.H. Practice Guidelines: A new reality in medicine: 1. Recent developments // Arch Intern Med.-1990.- Vol. 150.- P. 1811−1818.
- World Health Organization Expert Committee. The selec-tion of essential drugs. — Geneva: World Health Organi-zation, 1977.
- Wyatt J.C. Practice guidelines and other support for clinical innovation // J R Soc Med, — 2000.- Vol. 93.- P. 299−304.